# Charles River Laboratories International, Inc. (CRL): MoatMap facts

As of 29 Oct 2026. Research data, not investment advice.

As of 29 Oct 2026, MoatMap's StockRank for Charles River Laboratories International, Inc. (CRL) is 62/100, ranked against 24,000+ stocks in 35 markets (Quality 45, Value 28, Momentum 84, each scored against its sector).

- StockRank: 62/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 45, Value 28, Momentum 84: each a 0-100 percentile within Healthcare.
- Position: #10,167 overall, #983 in Healthcare.
- Listing: United States, NYQ; Healthcare / Diagnostics & Research.
- Last close: 373.98 USD on 28 Oct 2026.
- Insider filings, last 180 days: directors bought USD 3K; directors sold USD 52.1M.
- Buybacks, last 180 days: the company bought back USD 680.6M on 1 day.

Source: https://moatmap.ai/stock/CRL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker